Drug recall · December 17, 2025
Lanthanum Carbonate chewable tablets recall
Why: Failed stability specifications: Out of specification for hardness test
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.
- Lots / codes
lot# NB240315, exp 12/31/2025
- Quantity
- 1180 boxes
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- Nationwide in the USA
- Initiated
- October 24, 2025 · Voluntary: Firm initiated
- Classified
- December 5, 2025
- Reported
- December 17, 2025
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lanthanum carbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.